Search Orphan Drug Designations and Approvals
-
| Generic Name: | Monoclonal antiendotoxin antibody XMMEn-0e5 |
|---|---|
| Date Designated: | 11/04/1985 |
| Orphan Designation: | Treatment of patients with gram-negative sepsis which has progressed to shock. |
| Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Pfizer, Inc. 235 East 42nd Street New York, New York 10017 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







